Cargando…
A novel method for finding non-small cell lung cancer diagnosis biomarkers
BACKGROUND: One of the most common causes of worldwide cancer premature death is non-small cell lung carcinoma (NSCLC) with a very low survival rate of 8%-15%. Since patients with an early stage diagnosis can have up to four times the survival rate, discovering cost-effective biological markers that...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552706/ https://www.ncbi.nlm.nih.gov/pubmed/23369236 http://dx.doi.org/10.1186/1755-8794-6-S1-S11 |